Structure–Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c01651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Hao Zhang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
With increasing reports of resistance to artemisinins and artemisinin-combination therapies, targeting the Plasmodium proteasome is a promising strategy for antimalarial development. We recently reported a highly selective Plasmodium falciparum proteasome inhibitor with anti-malarial activity in the humanized mouse model. To balance the permeability of the series of macrocycles with other drug-like properties, we conducted further structure-activity relationship studies on a biphenyl ether-tethered macrocyclic scaffold. Extensive SAR studies around the P1, P3, and P5 groups and peptide backbone identified compound TDI-8414. TDI-8414 showed nanomolar antiparasitic activity, no toxicity to HepG2 cells, high selectivity against the Plasmodium proteasome over the human constitutive proteasome and immunoproteasome, improved solubility and PAMPA permeability, and enhanced metabolic stability in microsomes and plasma of both humans and mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.
- Tri-Institutional Therapeutics Discovery Institute, 413 E. 69th St., New York, New York 10065, United States.
- Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, New York 10065, United States.
- Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States.
- Infectious Diseases Research Collaboration, Kampala, Uganda.
- Schrödinger, Inc., New York, New York 10036, United States.
ORCID-Profile: Hao Zhang, Thijs Beuming, Peter T Meinke, Gang Lin
Förderung
- NIAID NIH HHS
- NIH HHS
Zitieren
APA
Zhang, H., Ginn, J., Zhan, W., Leung, A., Liu, Y. J., Toita, A., Okamoto, R., Wong, T. T., Imaeda, T., Hara, R., Michino, M., Yukawa, T., Chelebieva, S., Tumwebaze, P. K., Vendome, J., Beuming, T., Sato, K., Aso, K., Rosenthal, P. J., …, & Lin, G. (2023). Structure–Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01651
Vancouver
Zhang H, Ginn J, Zhan W, Leung A, Liu YJ, Toita A, et al. Structure–Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01651
BibTeX
@article{Zhang2023,
author = {Zhang, Hao and Ginn, John and Zhan, Wenhu and Leung, Annie and Liu, Yi J and Toita, Akinori and Okamoto, Rei and Wong, Tzu-Tshin and Imaeda, Toshihiro and Hara, Ryoma and Michino, Mayako and Yukawa, Takafumi and Chelebieva, Sevil and Tumwebaze, Patrick K and Vendome, Jeremie and Beuming, Thijs and Sato, Kenjiro and Aso, Kazuyoshi and Rosenthal, Philip J and Cooper, Roland A and Liverton, Nigel and Foley, Michael and Meinke, Peter T and Nathan, Carl F and Kirkman, Laura A and Lin, Gang},
title = {Structure–Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c01651}
}
EUVIMED